. . . . . . . . . "cabometyx is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma rcc 1 1 patients with hepatocellular carcinoma hcc who have been previously treated with sorafenib 1 2 cabometyx is indicated for the treatment of patients with advanced renal cell carcinoma rcc cabometyx is indicated for the treatment of patients with hepatocellular carcinoma hcc who have been previously treated with sorafenib" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "PY9rsFvFt/S93YflYkvFgbzlrUUbuMVBD8sZfUfDtMdJ9WP/OQwukmL7JhLyTFowArBc4xkPNuWFYgN5xqhOxKhXatuA8VL1C7obn4mI0T//jDaPt4piItZ1XeYroK4JQQbOtGrCzaquv4VTFgRTR+6myIOjWosjZ1eCqZsISiI=" . . "2021-06-12T12:21:44.793+02:00"^^ . . . . .